SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
68 hedge funds and large institutions have $224M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $251M → $224M (-$26.8M)
Holders
68
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.54M | |
| 2 | +$2.46M | |
| 3 | +$1.77M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.72M |
| 5 |
Millennium Management
New York
|
+$1.67M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$4.88M | |
| 3 | -$302K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$156K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$148K |